Quantum BioPharma Ltd.
QNTM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $1 | $2 | $4 |
| G&A Expenses | $4 | $4 | $2 | $2 |
| SG&A Expenses | $4 | $4 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $5 | $5 | $3 | $6 |
| Operating Income | -$5 | -$5 | -$3 | -$6 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | -$5 | -$5 | $1 |
| Pre-Tax Income | -$5 | -$10 | -$9 | -$5 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5 | -$9 | -$9 | -$5 |
| % Margin | – | – | – | – |
| EPS | -1.25 | -3.23 | -7.52 | -5.22 |
| % Growth | 61.3% | 57% | -44.1% | – |
| EPS Diluted | -1.25 | -3.23 | -7.52 | -5.22 |
| Weighted Avg Shares Out | 4 | 3 | 1 | 1 |
| Weighted Avg Shares Out Dil | 4 | 3 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$4 | -$9 | -$8 | -$5 |
| % Margin | – | – | – | – |